Biocell Technology (Newport Beach, CA) announced the appointment of Joosang Park, PhD, as vice president of scientific affairs, earlier this week. Park, who has direct research experience at Harvard Medical School and Stanford University, will be responsible for all research and development affairs related to patented and branded nutraceutical ingredients; namely BioCell Collagen II and i-Sabi.
Biocell Technology (Newport Beach, CA) announced the appointment of Joosang Park, PhD, as vice president of scientific affairs, earlier this week.
Park, who has direct research experience at Harvard Medical School and Stanford University, will be responsible for all research and development affairs related to patented and branded nutraceutical ingredients; namely BioCell Collagen II and i-Sabi.
The company has also announced the launch of its new wasabi japonica ingredient, i-Sabi, for brain health support. '[Research data] strongly supports that bioactive compounds, such as isothiocyanates in the wasabi rhizome extract, can exert a diverse range of physiological effects,'ÃÂ says Park. These effects include antioxidant, liver-protective, anti-inflammatory, and neuritogenic activities.
Park will be giving a presentation, 'BioCell Collagen II: A Natural Solution for Healthy Joints, Skin, and Aging,'ÃÂ at the upcoming Supply Side West conference at 8am on November, 12.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The Link Between Immune Health Benefits & Healthy, Active Lifestyles
January 11th 2024Better immune health means more healthy, active days – and who doesn’t want that? Now, we’re in an era where consumers want to be proactive about their immune health. Nutritional Outlook’s latest podcast highlights one key immune health ingredient, IMMUSE™, that brings a unique mode of action to activate pDCs (plasmacytoid dendritic cells)* — a pivotal leader within the immune system.